Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 39,000 shares on February 27, with a total net reduction of 93,900 shares over the last five trading days and 264,400 shares over the last 20 trading days [1] - As of now, southbound funds hold 5,587,400 shares of Gaoshi Medical, representing 3.77% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. primarily engages in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: proprietary products, distribution, technical services, and others [1] - The proprietary products segment develops and produces surgical equipment and related software, intraocular lenses, diagnostic and treatment equipment for eye diseases, and related consumables [1]

Core Viewpoint - Southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 18,800 shares on February 26, indicating a trend of net selling over the past trading days [1] Group 1: Southbound Fund Activity - In the last 5 trading days, southbound funds have reduced their holdings for 5 days, with a total net reduction of 78,100 shares [1] - Over the past 20 trading days, southbound funds have reduced their holdings for all 20 days, with a cumulative net reduction of 226,300 shares [1] - Currently, southbound funds hold 5,626,400 shares of Gaoshi Medical, accounting for 3.8% of the company's issued ordinary shares [1] Group 2: Company Overview - Gaoshi Medical Technology Co., Ltd. is primarily engaged in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates four segments: self-owned products, distribution, technical services, and other services [1] - The self-owned products segment develops and produces surgical equipment and related software, intraocular lenses, diagnostic and treatment equipment for eye diseases, and related consumables [1]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 7,500 shares on February 12, with a total net reduction of 60,300 shares over the past five trading days and 210,300 shares over the past twenty trading days [1] - As of now, southbound funds hold 5,645,200 shares of Gaoshi Medical, accounting for 3.81% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. primarily engages in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: self-owned products, distribution, technical services, and others [1] - The self-owned products segment develops and produces surgical equipment and related software, intraocular lenses, diagnostic and treatment equipment for eye diseases, and related consumables [1] - The distribution segment sells multifunctional diagnostic equipment, fundus diagnostic, surgical, and treatment equipment produced by other ophthalmic medical device manufacturers, along with related consumables [1] - The technical services segment provides warranty, maintenance, and after-sales services along with consumables used for these services [1] - The other segment mainly includes granting intellectual property rights and providing clinical research organization-related services [1]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 17,000 shares on February 11, with a total net reduction of 61,700 shares over the past five trading days and 203,800 shares over the past 20 trading days [1] - As of now, southbound funds hold 5,652,700 shares of Gaoshi Medical, representing 3.81% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. primarily engages in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: self-owned products, distribution, technical services, and others [1] - The self-owned products segment develops and produces surgical equipment and related software, intraocular lenses, diagnostic and treatment equipment for eye diseases, and related consumables [1]

Core Viewpoint - Southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) significantly over recent trading days, indicating a potential shift in investor sentiment towards the company [1]. Group 1: Shareholding Changes - On February 10, 2026, southbound funds reduced their holdings by 11,600 shares, bringing the total to 5,669,700 shares, which represents a decrease of 0.20% [2]. - Over the past five trading days, there has been a cumulative net reduction of 48,500 shares, with reductions occurring on all five days [1]. - In the last twenty trading days, the total net reduction reached 197,000 shares, with reductions on all twenty days [1]. Group 2: Company Overview - Gaoshi Medical Technology Co., Ltd. is primarily engaged in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [2]. - The company operates four segments: proprietary products, distribution, technical services, and other services, including clinical research organization services [2].

Core Viewpoint - Southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 23,200 shares on February 5, indicating a consistent trend of net selling over recent trading days [1] Group 1: Southbound Fund Activity - In the past 5 trading days, southbound funds have reduced their holdings for 5 days, with a total net reduction of 42,900 shares [1] - Over the last 20 trading days, southbound funds have reduced their holdings for all 20 days, resulting in a cumulative net reduction of 188,000 shares [1] - Currently, southbound funds hold 5,681,300 shares of Gaoshi Medical, accounting for 3.83% of the company's total issued ordinary shares [1] Group 2: Company Overview - Gaoshi Medical Technology Co., Ltd. is primarily engaged in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: proprietary products, distribution, technical services, and other services [1] - The proprietary products segment develops and produces surgical equipment, related software, intraocular lenses, and diagnostic and treatment devices for eye diseases [1]

Group 1 - The core point of the article is that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 900 shares on January 8, 2026, marking a trend of consistent reduction over recent trading days [1] - In the last 5 trading days, southbound funds have reduced their holdings for 5 days, with a total net reduction of 93,600 shares [1] - Over the past 20 trading days, there has been a total net reduction of 220,500 shares, indicating a sustained decrease in holdings [1] Group 2 - As of January 8, 2026, southbound funds hold 5.7582 million shares of Gaoshi Medical, which represents 3.88% of the company's total issued ordinary shares [1] - The shareholding changes over the last few trading days show a slight decline, with a maximum reduction of 72,200 shares on December 30, 2025, which corresponds to a 1.23% decrease [2] - Gaoshi Medical Technology Co., Ltd. is primarily engaged in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables, operating through four segments [2]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 2,800 shares on December 22, with a total net reduction of 30,700 shares over the last five trading days and 155,200 shares over the last twenty trading days [1] - As of now, southbound funds hold 5,852,700 shares of Gaoshi Medical, which represents 3.95% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. primarily engages in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: proprietary products, distribution, technical services, and others [1] - The proprietary products segment develops and produces surgical equipment and related software, intraocular lenses, diagnostic and treatment equipment for eye diseases, and related consumables [1] - The distribution segment sells multifunctional diagnostic equipment, fundus diagnostic, surgical, and treatment equipment produced by other ophthalmic medical device manufacturers, along with related consumables [1] - The technical services segment provides warranty services, maintenance services, and consumables used for after-sales services [1] - The other segment mainly includes granting intellectual property rights and providing clinical research organization-related services [1]

Group 1 - The core point of the news is that Southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 2,900 shares on December 9, 2025, marking a continuous trend of reduction over the past trading days [1] - In the last 5 trading days, Southbound funds have cumulatively reduced their holdings by 70,500 shares, while in the last 20 trading days, the total reduction amounts to 151,000 shares [1] - As of now, Southbound funds hold 5,908,200 shares of Gaoshi Medical, which represents 3.99% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. is primarily engaged in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [2] - The company operates through four segments: proprietary products, distribution, technical services, and other services, including clinical research organization services [2] - The proprietary products segment develops and produces surgical equipment, related software, intraocular lenses, and diagnostic and treatment equipment for eye diseases [2]